Gonçalo Bernardes
Gonçalo Bernardes
Group Leader - Department Chemistry, University of Cambridge
Verified email at cam.ac.uk
TitleCited byYear
Chemical modification of proteins at cysteine: opportunities in chemistry and biology
JM Chalker, GJL Bernardes, YA Lin, BG Davis
Chemistry–An Asian Journal 4 (5), 630-640, 2009
Advances in chemical protein modification
O Boutureira, GJL Bernardes
Chemical reviews 115 (5), 2174-2195, 2015
Allyl sulfides are privileged substrates in aqueous cross-metathesis: application to site-selective protein modification
YA Lin, JM Chalker, N Floyd, GJL Bernardes, BG Davis
Journal of the American Chemical Society 130 (30), 9642-9643, 2008
Facile conversion of cysteine and alkyl cysteines to dehydroalanine on protein surfaces: versatile and switchable access to functionalized proteins
GJL Bernardes, JM Chalker, JC Errey, BG Davis
Journal of the American Chemical Society 130 (15), 5052-5053, 2008
A “tag-and-modify” approach to site-selective protein modification
JM Chalker, GJL Bernardes, BG Davis
Accounts of chemical research 44 (9), 730-741, 2011
Developing drug molecules for therapy with carbon monoxide
CC Romao, WA Blättler, JD Seixas, GJL Bernardes
Chemical Society Reviews 41 (9), 3571-3583, 2012
Site-selective protein-modification chemistry for basic biology and drug development
N Krall, FP Da Cruz, O Boutureira, GJL Bernardes
Nature chemistry 8 (2), 103, 2016
Methods for converting cysteine to dehydroalanine on peptides and proteins
JM Chalker, SB Gunnoo, O Boutureira, SC Gerstberger, ...
Chemical Science 2 (9), 1666-1676, 2011
A small‐molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors
N Krall, F Pretto, W Decurtins, GJL Bernardes, CT Supuran, D Neri
Angewandte Chemie International Edition 53 (16), 4231-4235, 2014
Carbon‐Monoxide‐Releasing Molecules for the Delivery of Therapeutic CO In Vivo
S García‐Gallego, GJL Bernardes
Angewandte Chemie International Edition 53 (37), 9712-9721, 2014
CORM-3 Reactivity toward Proteins: The Crystal Structure of a Ru (II) Dicarbonyl− Lysozyme Complex
T Santos-Silva, A Mukhopadhyay, JD Seixas, GJL Bernardes, CC Romao, ...
Journal of the American Chemical Society 133 (5), 1192-1195, 2011
Inverse electron demand Diels–Alder reactions in chemical biology
BL Oliveira, Z Guo, GJL Bernardes
Chemical Society Reviews 46 (16), 4895-4950, 2017
From disulfide‐to thioether‐linked glycoproteins
GJL Bernardes, EJ Grayson, S Thompson, JM Chalker, JC Errey, ...
Angewandte Chemie International Edition 47 (12), 2244-2247, 2008
A traceless vascular‐targeting antibody–drug conjugate for cancer therapy
GJL Bernardes, G Casi, S Trüssel, I Hartmann, K Schwager, ...
Angewandte Chemie International Edition 51 (4), 941-944, 2012
The Direct Formation of Glycosyl Thiols from Reducing Sugars Allows One‐Pot Protein Glycoconjugation
GJL Bernardes, DP Gamblin, BG Davis
Angewandte Chemie International Edition 45 (24), 4007-4011, 2006
Posttranslational mutagenesis: A chemical strategy for exploring protein side-chain diversity
TH Wright, BJ Bower, JM Chalker, GJL Bernardes, R Wiewiora, WL Ng, ...
Science 354 (6312), aag1465, 2016
Curative properties of noninternalizing antibody–drug conjugates based on maytansinoids
E Perrino, M Steiner, N Krall, GJL Bernardes, F Pretto, G Casi, D Neri
Cancer research 74 (9), 2569-2578, 2014
Synthetically defined glycoprotein vaccines: current status and future directions
R Adamo, A Nilo, B Castagner, O Boutureira, F Berti, GJL Bernardes
Chemical science 4 (8), 2995-3008, 2013
Combined approaches to the synthesis and study of glycoproteins
GJL Bernardes, B Castagner, PH Seeberger
ACS Chemical Biology 4 (9), 703-713, 2009
Spontaneous CO release from RuII (CO) 2–protein complexes in aqueous solution, cells, and mice
M Chaves‐Ferreira, IS Albuquerque, D Matak‐Vinkovic, AC Coelho, ...
Angewandte Chemie International Edition 54 (4), 1172-1175, 2015
The system can't perform the operation now. Try again later.
Articles 1–20